Tokyo, Oct. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063207) titled 'Evaluation Study on Improvement of Canine Dementia by Intake of Plasma Collagen Derived from Chicken Breast' on Oct. 7.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - EAS

Condition: Condition - Canine Dementia Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - In elderly small dogs, we examine whether an 18-week intake of chicken breast-derived plasma rosa improves the dementia score (CCDR). Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Plasmalogen 1mg + Maltose 1g (powder, individually packaged 1g) Interventions/Control_2 - Maltose 1g (powder, non-individually packaged: serve in portions of total amount)

Eligibility: Age-lower limit - 10 years-old < Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Dogs aged 10 years or older and weighing 10 kg or less (excluding brachycephalic breeds) Owners can understand the explanation and obtain written consent Cognitive decline is suspected by the veterinarian, and CCDR evaluation is possible Continuous intake for 18 weeks, home visit evaluation, and blood collection available During the exam period, there is no intention to make significant changes to the living environment (diet, exercise, living conditions). Key exclusion criteria - Uncontrolled underlying conditions such as severe heart, kidney, liver disease, and endocrine disorders Frequent convulsive seizures and severe pain make behavior assessment difficult. Newly initiated or recent dosage changes of treatments/supplements that may affect cognitive function (duration fixed by operation) If the principal veterinarian deems it inappropriate Target Size - 10

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 09 Month 01 Day Date of IRB - 2026 Year 09 Month 15 Day Anticipated trial start date - 2026 Year 10 Month 07 Day Last follow-up date - 2027 Year 05 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071325

Disclaimer: Curated by HT Syndication.